©The Author(s) 2026.
World J Stem Cells. Jan 26, 2026; 18(1): 114119
Published online Jan 26, 2026. doi: 10.4252/wjsc.v18.i1.114119
Published online Jan 26, 2026. doi: 10.4252/wjsc.v18.i1.114119
Figure 1 Clinical trials status of mesenchymal stem cell-based therapies.
This pie chart displays the distribution of clinical trials related to mesenchymal stem cells, showing various statuses of these trials. The majority of trials are either completed (546 trials) or active but not recruiting (428 trials). A smaller number of trials are enrolled by invitation (281 trials) and seeking participants (62 trials). There are also trials that are suspended (24 trials), terminated (72 trials), withdrawn (11 trials), or have an unknown status (36 trials). Each section of the chart is color-coded to indicate the respective trial status. MSCs: Mesenchymal stem cells.
- Citation: Choudhery MS, Arif T, Mahmood R. Aging puzzle: A closer look on the complex dilemma of autologous stem cell therapy. World J Stem Cells 2026; 18(1): 114119
- URL: https://www.wjgnet.com/1948-0210/full/v18/i1/114119.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v18.i1.114119